Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

When injected into the bloodstream of rats with a nick in the femoral artery–the large artery in the thigh muscles–the nanoparticles bound activated platelets at the injury site. The treatment halved bleeding time in the rats from about four minutes to two, proving more effective than NovoSeven. The research was published this week in the journal Science Translational Medicine.

Lavik says the two treatments might prove to be complementary. NovoSeven, she says, “works to help build the fibrin mesh network that’s critical in building clot. Perhaps the synthetic platelets could help start building the clot and the drug might help stabilize it.”

“It sounds like it has the potential to be useful for controlling bleeding on the battlefield,” says John Weisel, a biologist at Penn Medical School, who was not involved in the research.

Early studies suggest the nanoparticles are safe, a major issue for treatments that enhance blood clotting. By studying fluorescently labeled versions of the nanoparticles, researchers found that the particles are easily cleared from the body. And the particles do not accumulate in noninjured tissue, such as the lungs or kidneys, to form dangerous clots. At very high doses–a concentration almost too thick to move through the syringe, says Lavik–the particles did trigger breathing issues in some animals. But such a high dose isn’t necessary to generate blood-clotting benefits, she says.

Nevertheless, extensive testing is needed before the particles can be used in humans. “The early research looks very promising, but the human system is different than a rat’s,” says Rutledge Ellis-Behnke, a researcher at MIT. “Care has to be taken that these do not coat the inside of the lungs and reduce the amount of oxygen transfer into red blood cells.”

Researchers plan to test the particles in larger animals, which more closely approximate the human circulatory system, as well as in different types of injuries, such as those that mimic the blast injuries that are particularly common among troops in Iraq and Afghanistan.

4 comments. Share your thoughts »

Credit: Science/AAAS
Video by AAAS/Science

Tagged: Biomedicine, blood, wound, healing

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me
×

A Place of Inspiration

Understand the technologies that are changing business and driving the new global economy.

September 23-25, 2014
Register »